Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Employment test 51 - 200 employees
Company dna barker brettell llp
no operation time available
Headquarter in Birmingham and 6 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 8 EP applications Jonathan David Myers has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after May 26, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14192835

A variant form of urate oxidase and use thereof

IPC classification:
A61K 38/44, A61K 47/48, C12N 9/06, C12N 9/72
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Jonathan David Myers, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP15156612

Variant forms of urate oxidase and use thereof

IPC classification:
A61K 47/48, C12N 9/06
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Jonathan David Myers, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP11755347

CHINESE HAMSTER OVARY CELL LINE

IPC classification:
C12N 5/16
Applicant:
MedImmune Limited
Agent:
Multiple attorneys, MedImmune Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14837645

PROBIOTIC STRAIN OF LACTOBACILLUS REUTERI EXHIBITING ANTI-HELICOBACTER ACTIVITY, A PROBIOTIC OR BIOTHERAPEUTIC PRODUCT COMPRISING SAID STRAIN, AND THE USE THEREOF

IPC classification:
A61K 35/74, C12N 1/20, C12R 1/225, A23L 33/10
Applicant:
Consejo Superior De Investigaciones Científicas (CSIC)
Agent:
Jonathan David Myers, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13165968

Immunogenic nanomedicine composition and preparation and uses thereof

IPC classification:
A61K 39/21
Agent:
Zsolt Lengyel, Danubia Patent and Law Office LLC
Agent:
Jonathan David Myers, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11741602

MONOMERIC POLYPEPTIDES COMPRISING VARIANT FC REGIONS AND METHODS OF USE

IPC classification:
C07K 16/28
Applicant:
MedImmune Limited
Agent:
Multiple attorneys, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15729929

REDUCING INTRON RETENTION

IPC classification:
C12N 15/11, C12N 15/113, C12Q 1/68
Agent:
Jonathan David Myers, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15867844

METHODS FOR TREATING AND PREVENTING CARDIOMYOPATHY

IPC classification:
C07K 14/005, C07K 14/435, C07K 14/50
Applicant:
The University of Washington
Agent:
Jonathan David Myers, Barker Brettell LLP
Status:
Request for examination was made

Please Sign in to use this feature